CP Plus Reports Strong Q4 Growth Net Profit Triples to 169 Crore Revenue Jumps 45 Traders Now Price Fed Rate Hike as Next Move Following Inflation Surge AIs Potential to Accelerate Drug Discovery for Brain Conditions A New Frontier for Biotech Taiwan Weighted Index Closes 027 Lower Amid Market Caution Iran and US Explore 60Day Nuclear Deal Uranium Enrichment Sanctions Relief and Frozen Funds on Table Hindalco Reports 51 Decline in Q4 Net Profit Board Declares Rs 5 Dividend Info Edge Q4FY26 Results Consolidated Net Profit Up 22 YoY to Rs 566 Crore Revenue Climbs 16